Home › Therapeutic areas › Oncology › Gastric Cancer

Gastric Cancer (10 companies)

Companies with an active program in Gastric Cancer.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ALLO Allogene Therapeutics ImmunologyOncology Rare 1 Phase 2 $256M 10
ARTV Artiva Biotherapeutics Oncology 1 Phase 1 $191M 6
CGEN Compugen Oncology 1 Phase 3 $191M 7
CBIO Crescent Biopharma Oncology 1 Phase 2 $507M 10
CTMX CytomX Therapeutics Oncology 1 Phase 1 $423M 7
KAPA Kairos Pharma Oncology 1 Phase 2 $1.9M 12
LEGN Legend Biotech Oncology Rare 1 Approved $3.12B 17
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 $47.7M 8
NBP NovaBridge Biosciences OncologyOphthalmology 1 Phase 2 $95.4M 7
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved $2.59B 28